Imaging the Invisible with No Labels: A Major Opportunity in Biology and Medicine

在没有标签的情况下对不可见的物体进行成像:生物学和医学的一个重大机遇

基本信息

  • 批准号:
    8531699
  • 负责人:
  • 金额:
    $ 75.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Small molecules such as metabolites and drugs are crucial to the biochemistry of living organisms because of their large diversity and the sheer number present. Unlike their large molecule counter parts such proteins, DNA and mRNA, most of these species are invisible in a living cell or organism because of technical difficulties. Tagging them with bulky fluorescent labels perturbs their function. Label-free optical imaging based on Raman scattering is highly desirable because it offers contrast based on the intrinsic chemical properties of molecules via molecular vibrational spectroscopy, but has been limited to low sensitivity and long acquisition times. Our group has recently developed stimulated Raman scattering (SRS) microscopy, which offers an unprecedented combination of high sensitivity, rapid image acquisition, chemical specificity and noninvasiveness. The development of SRS microscopy has generated a great of interest from the biomedical research community and studies of lipid metabolism and drug distributions in tissue are already underway in our laboratory. We propose to continue the pioneering development in order to probe lipid metabolism, including lipogenesis, lipolysis and insulin resistance. We will image not only different types of lipids, such as saturated and unsaturated lipids and cholesterol, but also key metabolites, such as glucose, ATP, ADP, and small molecule drugs as well, all in living cells and tissue without the use of perturbative labels. These new experiments will no doubt allow new observations that will enrich our knowledge of cellular biochemistry. We will also develop all-optical cancer markers and use SRS to bring about a new paradigm for intra-operative imaging of brain tumors, improving the surgical outcome by shortening surgery and allowing more precise definition of tumor margins. The widespread adoption of SRS and the discovery of new applications will revolutionize many areas of biomedical research, including lipid metabolism, pharmacokinetics and cancer diagnosis.
描述(由申请人提供):小分子如代谢物和药物对生物体的生物化学至关重要,因为它们具有很大的多样性和存在的绝对数量。与它们的大分子对应物如蛋白质、DNA和mRNA不同,由于技术困难,这些物种中的大多数在活细胞或生物体中是不可见的。用大体积的荧光标记物标记它们会干扰它们的功能。基于拉曼散射的无标记光学成像是高度期望的,因为其经由分子振动光谱提供基于分子的固有化学性质的对比度,但是受限于低灵敏度和长采集时间。我们的小组最近开发了受激拉曼散射(SRS)显微镜,它提供了一个前所未有的高灵敏度,快速图像采集,化学特异性和非侵入性的组合。SRS显微镜的发展已经产生了极大的兴趣,从生物医学研究界和组织中的脂质代谢和药物分布的研究已经在我们的实验室进行。我们建议继续开拓性的发展,以探测脂质代谢,包括脂肪生成,脂解和胰岛素抵抗。我们不仅将成像不同类型的脂质,如饱和和不饱和脂质和胆固醇,而且还将成像关键代谢物,如葡萄糖,ATP,ADP和小分子药物,所有这些都在活细胞和组织中,而无需使用微扰标记。这些新的实验无疑将允许新的观察,这将丰富我们的细胞生物化学知识。我们还将开发全光学癌症标记物,并使用SRS为脑肿瘤的术中成像带来新的范例,通过缩短手术时间和更精确地定义肿瘤边缘来改善手术结果。SRS的广泛采用和新应用的发现将彻底改变生物医学研究的许多领域,包括脂质代谢、药代动力学和癌症诊断。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
In vivo metabolic fingerprinting of neutral lipids with hyperspectral stimulated Raman scattering microscopy.
  • DOI:
    10.1021/ja504199s
  • 发表时间:
    2014-06-18
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Fu, Dan;Yu, Yong;Folick, Andrew;Currie, Erin;Farese, Robert V., Jr.;Tsai, Tsung-Huang;Xie, Xiaoliang Sunney;Wang, Meng C.
  • 通讯作者:
    Wang, Meng C.
Label-free live-cell imaging of nucleic acids using stimulated Raman scattering microscopy.
Quantitative chemical imaging with multiplex stimulated Raman scattering microscopy.
  • DOI:
    10.1021/ja210081h
  • 发表时间:
    2012-02-29
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Fu, Dan;Lu, Fa-Ke;Zhang, Xu;Freudiger, Christian;Pernik, Douglas R.;Holtom, Gary;Xie, Xiaoliang Sunney
  • 通讯作者:
    Xie, Xiaoliang Sunney
Coherent nonlinear optical imaging: beyond fluorescence microscopy.
  • DOI:
    10.1146/annurev.physchem.012809.103512
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    14.7
  • 作者:
    Min W;Freudiger CW;Lu S;Xie XS
  • 通讯作者:
    Xie XS
Stimulated Raman Scattering Microscopy with a Robust Fibre Laser Source.
  • DOI:
    10.1038/nphoton.2013.360
  • 发表时间:
    2014-02-01
  • 期刊:
  • 影响因子:
    35
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

XIAOLIANG SUNNEY XIE其他文献

XIAOLIANG SUNNEY XIE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('XIAOLIANG SUNNEY XIE', 18)}}的其他基金

Area A: High Precision Single Cell Genomes: Linear Amplification and Digital Haplotypes
A 区:高精度单细胞基因组:线性扩增和数字单倍型
  • 批准号:
    9483092
  • 财政年份:
    2017
  • 资助金额:
    $ 75.92万
  • 项目类别:
Probing Dynamics of The Human Genome by Single Cell Sequencing
通过单细胞测序探测人类基因组的动态
  • 批准号:
    8906832
  • 财政年份:
    2013
  • 资助金额:
    $ 75.92万
  • 项目类别:
Probing Dynamics of The Human Genome by Single Cell Sequencing
通过单细胞测序探测人类基因组的动态
  • 批准号:
    8738632
  • 财政年份:
    2013
  • 资助金额:
    $ 75.92万
  • 项目类别:
Probing Dynamics of The Human Genome by Single Cell Sequencing
通过单细胞测序探测人类基因组的动态
  • 批准号:
    8564337
  • 财政年份:
    2013
  • 资助金额:
    $ 75.92万
  • 项目类别:
Dynamic cellular architecture of bacteria by system-wide super-resolution imaging
通过全系统超分辨率成像研究细菌的动态细胞结构
  • 批准号:
    8726432
  • 财政年份:
    2010
  • 资助金额:
    $ 75.92万
  • 项目类别:
Dynamic cellular architecture of bacteria by system-wide super-resolution imaging
通过全系统超分辨率成像研究细菌的动态细胞结构
  • 批准号:
    8151043
  • 财政年份:
    2010
  • 资助金额:
    $ 75.92万
  • 项目类别:
Dynamic cellular architecture of bacteria by system-wide super-resolution imaging
通过全系统超分辨率成像研究细菌的动态细胞结构
  • 批准号:
    8015884
  • 财政年份:
    2010
  • 资助金额:
    $ 75.92万
  • 项目类别:
Dynamic cellular architecture of bacteria by system-wide super-resolution imaging
通过全系统超分辨率成像研究细菌的动态细胞结构
  • 批准号:
    8325097
  • 财政年份:
    2010
  • 资助金额:
    $ 75.92万
  • 项目类别:
Dynamic cellular architecture of bacteria by system-wide super-resolution imaging
通过全系统超分辨率成像研究细菌的动态细胞结构
  • 批准号:
    8537949
  • 财政年份:
    2010
  • 资助金额:
    $ 75.92万
  • 项目类别:
Real-time single-molecule nucleic acid sequencing with fluorogenic nucleotides
使用荧光核苷酸进行实时单分子核酸测序
  • 批准号:
    8136799
  • 财政年份:
    2010
  • 资助金额:
    $ 75.92万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 75.92万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 75.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 75.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 75.92万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 75.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 75.92万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 75.92万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 75.92万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 75.92万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 75.92万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了